Evidence map›Paper›PMID 25918688›Full record

ArticleFrontiers in oncology2015

Human colon-derived soluble factors modulate gut microbiota composition.

Arancha Hevia, David Bernardo, Enrique Montalvillo, Hafid O Al-Hassi, Luis Fernández-Salazar, Jose A Garrote, Christian Milani, Marco Ventura, Eduardo Arranz, Stella C Knight and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Arancha HeviaDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias - Consejo Superior de Investigaciones Científicas (IPLA-CSIC) , Villaviciosa , Spain.
David BernardoAntigen Presentation Research Group, Imperial College London , Harrow , UK ; Gastroenterology Unit, Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) , Madrid , Spain.
Enrique MontalvilloMucosal Immunology Laboratory, Instituto de Biología y Genética Molecular (IBGM), University of Valladolid-CSIC , Valladolid , Spain.
Hafid O Al-HassiAntigen Presentation Research Group, Imperial College London , Harrow , UK.
Luis Fernández-SalazarGastroenterology Service, Hospital Clinico Universitario de Valladolid , Valladolid , Spain.
Jose A GarroteMucosal Immunology Laboratory, Instituto de Biología y Genética Molecular (IBGM), University of Valladolid-CSIC , Valladolid , Spain ; Clinical Laboratory Service, Department of Genetics and Molecular Biology, Hospital Universitario Rio Hortega , Valladolid , Spain.
Christian MilaniLaboratory of Probiogenomics, Department of Life Sciences, University of Parma , Parma , Italy.
Marco VenturaLaboratory of Probiogenomics, Department of Life Sciences, University of Parma , Parma , Italy.
Eduardo ArranzMucosal Immunology Laboratory, Instituto de Biología y Genética Molecular (IBGM), University of Valladolid-CSIC , Valladolid , Spain.
Stella C KnightAntigen Presentation Research Group, Imperial College London , Harrow , UK.
Abelardo MargollesDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias - Consejo Superior de Investigaciones Científicas (IPLA-CSIC) , Villaviciosa , Spain.
Borja SánchezNutrition and Bromatology Group, Department of Analytical and Food Chemistry, Food Science and Technology Faculty, University of Vigo , Ourense , Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The commensal microbiota modulates immunological and metabolic aspects of the intestinal mucosa contributing to development of human gut diseases including inflammatory bowel disease. The host/microbiota interaction often referred to as a crosstalk, mainly focuses on the effect of the microbiota on the host neglecting effects that the host could elicit on the commensals. Colonic microenvironments from three human healthy controls (obtained from the proximal and distal colon, both in resting conditions and after immune - IL-15- and microbiota - LPS-in vitro challenges) were used to condition a stable fecal population. Subsequent 16S rRNA gene-based analyses were performed to study the effect induced by the host on the microbiota composition and function. Non-supervised principal component analysis (PCA) showed that all microbiotas, which had been conditioned with colonic microenvironments clustered together in terms of relative microbial composition, suggesting that soluble factors were modulating a stable fecal population independently from the treatment or the origin. Our findings confirmed that the host intestinal microenvironment has the capacity to modulate the gut microbiota composition via yet unidentified soluble factors. These findings indicate that an appropriate understanding of the factors of the host mucosal microenvironment affecting microbiota composition and function could improve therapeutic manipulation of the microbiota composition.

Indexed as

host–microbiota interactionmetagenomicsmicrobial modulationmolecular crosstalksoluble mediators

Identifiers

PMID25918688
PMCPMC4394693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.